SCHEMBL25976393

SCHEMBL25976393

C=CC[C@@H]1O[C@H](CC)[C@H](C)[C@H](C)[C@H]1N1C(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25432282 0.71 CYP3A4 (0.31) —
SCHEMBL22559758 0.70 TSHR (0.39) —
SCHEMBL25985225 0.70 TSHR (0.39) —
SCHEMBL30180532 0.70 TSHR (0.39) —
SCHEMBL26922977 0.62 — —
SCHEMBL15982001 0.60 CYP2C19 (0.32) —
SCHEMBL18020648 0.60 CYP2C19 (0.32) —
SCHEMBL19546106 0.59 — —
SCHEMBL17087891 0.58 CYP2C19 (0.33) —
SCHEMBL531356 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250091-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. 2023-08-10 — — US disclosed
Send feedback